Rheumatoid factor is associated with the distribution of hand joint destruction in rheumatoid arthritis

Arthritis and Rheumatology

Volumn 67, Issue 12, 2015, Pages 3113-3123

  Terao, Chikashi ^a,b,g   Yamakawa, Noriyuki ^b   Yano, Koichiro ^c   Markusse, Iris M ^d   Ikari, Katsunori ^c   Yoshida, Shinji ^c   Furu, Moritoshi ^b   Hashimoto, Motomu ^b   Ito, Hiromu ^b   Fujii, Takao ^b   Ohmura, Koichiro ^b   Murakami, Kosaku ^b   Takahashi, Meiko ^b   Hamaguchi, Masahide ^e   Tabara, Yasuharu ^b   Taniguchi, Atsuo ^c   Momohara, Shigeki ^c   Raychaudhuri, Soumya ^a,f,g   Allaart, Cornelia F ^d   Yamanaka, Hisashi ^c   Mimori, Tsuneyo ^b   Matsuda, Fumihiko ^b   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^f UNIVERSITY OF MANCHESTER   (United Kingdom)

^g BROAD INSTITUTE OF MIT AND HARVARD   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; RHEUMATOID FACTOR; ANTIRHEUMATIC AGENT; AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE; HLA DRB1 ANTIGEN; METHOTREXATE;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ASSESSMENT TOOL; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE DURATION; FEMALE; FINGER JOINT; HAND BONE; HAND JOINT; HUMAN; JAPANESE (PEOPLE); JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SHARP VAN DER HEIJDE SCORE; SMOKING; AGED; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; DISEASE COURSE; FOOT JOINT; GENETICS; IMMUNOLOGY; JAPAN; NETHERLANDS; RADIOGRAPHY; SEVERITY OF ILLNESS INDEX; STATISTICAL MODEL;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; AUTOANTIBODIES; COHORT STUDIES; DISEASE PROGRESSION; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; FINGER JOINT; FOOT JOINTS; HAND JOINTS; HLA-DRB1 CHAINS; HUMANS; JAPAN; LINEAR MODELS; MALE; METHOTREXATE; MIDDLE AGED; NETHERLANDS; PEPTIDES, CYCLIC; RHEUMATOID FACTOR; SEVERITY OF ILLNESS INDEX;

EID: 84948420763     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.39306     Document Type: Article

References (31)

1. Terao C., Genetic contribution to susceptibility and disease phenotype in rheumatoid arthritis. Inflamm Regen 2014; 34: 71-7.
2. Drossaers-Bakker KW, de Buck M, van Zeben D, Zwinderman AH, Breedveld FC, Hazes JM., Long-term course and outcome of functional capacity in rheumatoid arthritis: the effect of disease activity and radiologic damage over time. Arthritis Rheum 1999; 42: 1854-60.
3. Smolen JS, van der Heijde DM, St.Clair EW, Emery P, Bathon JM, Keystone E, et al, for the Active-Controlled Study of Patients Receiving Infliximab for the Treatment of Rheumatoid Arthritis of Early Onset (ASPIRE) Study Group. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 2006; 54: 702-10.
4. Sharp JT, Lidsky MD, Collins LC, Moreland J., Methods of scoring the progression of radiologic changes in rheumatoid arthritis: correlation of radiologic, clinical and laboratory abnormalities. Arthritis Rheum 1971; 14: 706-20.
5. Sharp JT, Bluhm GB, Brook A, Brower AC, Corbett M, Decker JL, et al., Reproducibility of multiple-observer scoring of radiologic abnormalities in the hands and wrists of patients with rheumatoid arthritis. Arthritis Rheum 1985; 28: 16-24.
6. Van der Heijde DM., How to read radiographs according to the Sharp/van der Heijde method [corrected and republished in J Rheumatol 2000;27:261-3]. J Rheumatol 1999; 26: 743-5.
7. Gregersen PK, Silver J, Winchester RJ., The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30: 1205-13.
8. Suzuki T, Ikari K, Yano K, Inoue E, Toyama Y, Taniguchi A, et al., PADI4 and HLA-DRB1 are genetic risks for radiographic progression in RA patients, independent of ACPA status: results from the IORRA cohort study. PLoS One 2013; 8: e61045.
9. Scherer HU, van der Woude D, Willemze A, Trouw LA, Knevel R, Syversen SW, et al., Distinct ACPA fine specificities, formed under the influence of HLA shared epitope alleles, have no effect on radiographic joint damage in rheumatoid arthritis. Ann Rheum Dis 2011; 70: 1461-4.
10. Van der Cruyssen B, Hoffman IE, Peene I, Union A, Mielants H, Meheus L, et al., Prediction models for rheumatoid arthritis during diagnostic investigation: evaluation of combinations of rheumatoid factor, anti-citrullinated protein/peptide antibodies and the human leucocyte antigen-shared epitope. Ann Rheum Dis 2007; 66: 364-9.
11. Panayi GS, Celinska E, Emery P, Griffin J, Welsh KI, Grahame R, et al., Seronegative and seropositive rheumatoid arthritis: similar diseases. Br J Rheumatol 1987; 26: 172-80.
12. Terao C, Hashimoto M, Yamamoto K, Murakami K, Ohmura K, Nakashima R, et al., Three groups in the 28 joints for rheumatoid arthritis synovitis: analysis using more than 17,000 assessments in the KURAMA database. PLoS One 2013; 8: e59341.
13. Terao C, Ohmura K, Ikari K, Kawaguchi T, Takahashi M, Setoh K, et al., Effects of smoking and shared epitope on the production of anticitrullinated peptide antibody in a Japanese adult population. Arthritis Care Res (Hoboken) 2014; 66: 1818-27.
14. Terao C, Ohmura K, Kochi Y, Ikari K, Maruya E, Katayama M, et al., A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects. Ann Rheum Dis 2011; 70: 2134-9.
15. Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, van Zeben D, Kerstens PJ, Hazes JM, et al., Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005; 52: 3381-90.
16. Okada Y, Kim K, Han B, Pillai NE, Ong RT, Saw WY, et al., Risk for ACPA-positive rheumatoid arthritis is driven by shared HLA amino acid polymorphisms in Asian and European populations. Hum Mol Genet 2014; 23: 6916-26.
17. Terao C, Yano K, Ikari K, Furu M, Yamakawa N, Yoshida S, et al., Main contribution of DRB 04:05 among the shared epitope alleles and involvement of DRB1 amino acid position 57 in association with joint destruction in anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2015; 67: 1744-50.
18. Terao C, Ohmura K, Katayama M, Takahashi M, Kokubo M, Diop G, et al., Myelin basic protein as a novel genetic risk factor in rheumatoid arthritis: a genome-wide study combined with immunological analyses. PLoS One 2011; 6: e20457.
19. Ohmura K, Terao C, Maruya E, Katayama M, Matoba K, Shimada K, et al., Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis. Rheumatology (Oxford) 2010; 49: 2298-304.
20. Terao C, Ikari K, Ohmura K, Suzuki T, Iwamoto T, Takasugi K, et al., Quantitative effect of HLA-DRB1 alleles to ACPA levels in Japanese rheumatoid arthritis: no strong genetic impact of shared epitope to ACPA levels after stratification of HLA-DRB109:01. Ann Rheum Dis 2012; 71: 1095-7.
21. Han B, Diogo D, Eyre S, Kallberg H, Zhernakova A, Bowes J, et al., Fine mapping seronegative and seropositive rheumatoid arthritis to shared and distinct HLA alleles by adjusting for the effects of heterogeneity. Am J Hum Genet 2014; 94: 522-32.
22. Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al., Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 2012; 44: 291-6.
23. Terao C, Ohmura K, Ikari K, Kochi Y, Maruya E, Katayama M, et al., ACPA-negative RA consists of two genetically distinct subsets based on RF positivity in Japanese. PLoS One 2012; 7: e40067.
24. Schellekens GA, Visser H, de Jong BA, van den Hoogen FH, Hazes JM, Breedveld FC, et al., The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
25. Bukhari M, Thomson W, Naseem H, Bunn D, Silman A, Symmons D, et al., The performance of anti-cyclic citrullinated peptide antibodies in predicting the severity of radiologic damage in inflammatory polyarthritis: results from the Norfolk Arthritis Register. Arthritis Rheum 2007; 56: 2929-35.
26. Terao C, Ohmura K, Kochi Y, Ikari K, Okada Y, Shimizu M, et al., Anti-citrullinated peptide/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population. Arthritis Res Ther 2015; 17: 104.
27. Terao C, Suzuki A, Ikari K, Kochi Y, Ohmura K, Katayama M, et al., An association between amino acid position 74 of HLA-DRB1 and anti-citrullinated protein antibody levels in Japanese patiests with anti-citrullinated protein antibody-positive rheumatoid arthritis. Arthritis Rheumatol 2015: 67: 2038-45.
28. Hashimoto J, Garnero P, van der Heijde D, Miyasaka N, Yamamoto K, Kawai S, et al., Humanized anti-interleukin-6-receptor antibody (tocilizumab) monotherapy is more effective in slowing radiographic progression in patients with rheumatoid arthritis at high baseline risk for structural damage evaluated with levels of biomarkers, radiography, and BMI: data from the SAMURAI study. Mod Rheumatol 2011; 21: 10-5.
29. Hashiramoto A, Shiozawa K, Tanaka Y, Yamane T, Murata M, Tanaka C, et al., Prospective study of methotrexate treatment for rheumatoid arthritis treated legitimately according to the government recommended 8 mg/week dose. Mod Rheumatol 2009; 19: 637-42.
30. Vainio K., The rheumatoid foot: a clinical study with pathological and roentgenological comments. Ann Chir Gynaecol Fenn Suppl 1956; 45: 1-107.
31. Navarro-Compan V, Landewe R, Provan SA, Odegard S, Uhlig T, Kvien TK, et al., Relationship between types of radiographic damage and disability in patients with rheumatoid arthritis in the EURIDISS cohort: a longitudinal study. Rheumatology (Oxford) 2015; 54: 83-90.